509 related articles for article (PubMed ID: 30260323)
1. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
Huber V; Vallacchi V; Fleming V; Hu X; Cova A; Dugo M; Shahaj E; Sulsenti R; Vergani E; Filipazzi P; De Laurentiis A; Lalli L; Di Guardo L; Patuzzo R; Vergani B; Casiraghi E; Cossa M; Gualeni A; Bollati V; Arienti F; De Braud F; Mariani L; Villa A; Altevogt P; Umansky V; Rodolfo M; Rivoltini L
J Clin Invest; 2018 Dec; 128(12):5505-5516. PubMed ID: 30260323
[TBL] [Abstract][Full Text] [Related]
2. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
Front Immunol; 2020; 11():1214. PubMed ID: 32793185
[TBL] [Abstract][Full Text] [Related]
3. Pseudoneutrophil Cytokine Sponges Disrupt Myeloid Expansion and Tumor Trafficking to Improve Cancer Immunotherapy.
Li S; Wang Q; Shen Y; Hassan M; Shen J; Jiang W; Su Y; Chen J; Bai L; Zhou W; Wang Y
Nano Lett; 2020 Jan; 20(1):242-251. PubMed ID: 31790598
[TBL] [Abstract][Full Text] [Related]
4. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
5. miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
Zhang X; Li F; Tang Y; Ren Q; Xiao B; Wan Y; Jiang S
Oncogene; 2020 Oct; 39(40):6354-6369. PubMed ID: 32855524
[TBL] [Abstract][Full Text] [Related]
6. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
[TBL] [Abstract][Full Text] [Related]
7. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
[TBL] [Abstract][Full Text] [Related]
8. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
10. Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.
Sierra RA; Trillo-Tinoco J; Mohamed E; Yu L; Achyut BR; Arbab A; Bradford JW; Osborne BA; Miele L; Rodriguez PC
Cancer Res; 2017 Oct; 77(20):5628-5638. PubMed ID: 28904063
[TBL] [Abstract][Full Text] [Related]
11. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
[TBL] [Abstract][Full Text] [Related]
12. MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.
Xu Z; Ji J; Xu J; Li D; Shi G; Liu F; Ding L; Ren J; Dou H; Wang T; Hou Y
FEBS J; 2017 Aug; 284(15):2410-2424. PubMed ID: 28605567
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 449c Mediates the Generation of Monocytic Myeloid-Derived Suppressor Cells by Targeting STAT6.
Han X; Luan T; Sun Y; Yan W; Wang D; Zeng X
Mol Cells; 2020 Sep; 43(9):793-803. PubMed ID: 32863280
[TBL] [Abstract][Full Text] [Related]
14. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.
Holmgaard RB; Zamarin D; Lesokhin A; Merghoub T; Wolchok JD
EBioMedicine; 2016 Apr; 6():50-58. PubMed ID: 27211548
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
Valencia JC; Erwin-Cohen RA; Clavijo PE; Allen C; Sanford ME; Day CP; Hess MM; Johnson M; Yin J; Fenimore JM; Bettencourt IA; Tsuneyama K; Romero ME; Klarmann KD; Jiang P; Bae HR; McVicar DW; Merlino G; Edmondson EF; Anandasabapathy N; Young HA
Cancer Res; 2021 Dec; 81(23):5977-5990. PubMed ID: 34642183
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
17. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
[TBL] [Abstract][Full Text] [Related]
19. LPS expands MDSCs by inhibiting apoptosis through the regulation of the GATA2/let-7e axis.
Yang Y; Sun D; Zhou J; Tan C; Zhang H; Chen Z; Hao C; Zhang J
Immunol Cell Biol; 2019 Feb; 97(2):142-151. PubMed ID: 30221399
[TBL] [Abstract][Full Text] [Related]
20. Effective combinatorial immunotherapy for castration-resistant prostate cancer.
Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA
Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
